4 results  1 of 1 

1 Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
Sujin Choi, Bo Kyung Kim, Hong Yul Ahn, Kyung Taek Hong, Jung Yoon Choi, Hee Young Shin, Hyoung Jin Kang
Blood Res.2020;55(4):217-224.   Published online 2020 December 31     DOI: http://dx.doi.org/10.5045/br.2020.2020127
      
2 Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD
Dong Won Baek, Jung Min Lee, Ju-Hyung Kim, Hee Jeong Cho, Ji-Yeon Ham, Jang-Soo Suh, Sang-Kyun Sohn, Joon Ho Moon
Blood Res.2019;54(3):189-197.   Published online 2019 September 25     DOI: http://dx.doi.org/10.5045/br.2019.54.3.189
      
3 Fragment Analysis for Detection of the FLT3-Internal Tandem Duplication: Comparison with Conventional PCR and Sanger Sequencing
GunDong Lee, Jeongeun Kim, SangYoon Lee, Woori Jang, Joonhong Park, Hyojin Chae, Myungshin Kim, Yonggoo Kim
Lab Med Online.2017;7(1):13-19.   Published online 2017 January 17     DOI: http://dx.doi.org/10.3343/lmo.2017.7.1.13
   
4 Prognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemia
Yeo-Kyeoung Kim, Hee-Nam Kim, Se Ryeon Lee, Jae-Sook Ahn, Deok-Hwan Yang, Je-Jung Lee, Il-Kwon Lee, Myung-Geun Shin, Hyeoung-Joon Kim
Korean J Hematol.2010;45(1):36-45.   Published online 2010 March 31     DOI: http://dx.doi.org/10.5045/kjh.2010.45.1.36
      

 1 of 1